UCBJF News and Press, UCB SA From 08/29/25

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress PR Newswire 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living w...

2025-08-05 09:40:15 ET ... Read the full article on Seeking Alpha For further details see: Bayer Stock Is Soaring Ahead Of Its Earnings Release

2025-08-01 17:53:53 ET UCB SA (UCBJF) Q2 2025 Earnings Conference Call July 31, 2025, 8:00 AM ET Company Participants Antje Witte - Head of Investor Relations Emmanuel Caeymaex - Executive VP & Chief Commercial Officer Fiona du Monceau - Executive Vice Presid...

2025-07-31 09:55:05 ET More on UCB SA Seeking Alpha’s Quant Rating on UCB SA Historical earnings data for UCB SA Dividend scorecard for UCB SA Financial information for UCB SA Read the full article on Seeking Alpha For further details s...

2025-06-15 23:27:38 ET Headquartered in Bedford, MA, Stoke Therapeutics ( STOK ) was founded in 2014 with a focus on developing RNA-based medicines to treat severe diseases by increasing protein expression.... Read the full article on Seeking Alpha For further details see: ...

2025-06-14 10:30:00 ET Despite the war between Israel and Iran that began on June 13 , Amgen's ( AMGN ) stock price continues to hold above its VWAP [volume-weighted average price] and has gained about 15% in the last month.... Read the full article on Seeking ...

2025-05-05 12:50:00 ET Summary Fidelity® International Discovery Fund seeks long-term capital growth by investing in high-quality, non-U.S. stocks with strong fundamentals and attractive valuations. The fund's Retail Class shares gained 3.84% in Q1 2025, trailing the MSCI EAF...

2025-04-24 10:15:00 ET Summary Global markets were mixed in Q1, ending in a sharp and broad equity market selloff as investors awaited President Donald Trump’s announcement of further US tariffs. The portfolio solidly beat its primary and secondary benchmarks, the MSCI EAFE...

2025-04-13 23:50:00 ET Summary During the first quarter, the ClearBridge International Growth ACWI Ex-US Strategy outperformed its MSCI ACWI Ex-U.S. Index benchmark. The Strategy outperformed in a value-dominated market environment, supported by strength among communication servic...

2025-04-09 06:02:04 ET More on European drugmakers Novartis After Sandoz: The Business Without Generics AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy Novo Nordisk: Not As Bullish As Many Daiichi Sankyo and AstraZeneca...